Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 99MTC-EC0652, DUPA-99MTC, EC 0652 + [3] |
Target |
Mechanism PSMA modulators(Prostate-specific membrane antigen modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC47H58N9O18STc |
InChIKeyCYGMKSFSFBQDSV-NNSJRZNKSA-G |
CAS Registry1124317-67-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Phase 1 | US | 29 Sep 2018 |